UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis C: awareness Through to Treatment (HepCATT) study: evaluation of an intervention designed to increase diagnosis and treatment of patients with hepatitis C virus infection in drug treatment settings

Journal of hepatology, 2017, Vol.66 (1), p.S712-S713

2017

Volltextzugriff (PDF)

Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme

Journal of hepatology, 2017, Vol.66 (1), p.S746-S747

2017

Volltextzugriff (PDF)

Real world outcomes of DAA therapy for chronic hepatitis C virus infection in the HCV Research UK National cohort

Journal of hepatology, 2017, Vol.66 (1), p.S504-S504

2017

Volltextzugriff (PDF)

P1012 ENHANCED LIVER FIBROSIS (ELF) TEST PERFORMS BETTER THAN HISTOLOGICAL PARAMETERS IN PREDICTING CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED FIBROSIS DUE TO CHRONIC HEPATITIS C INFECTION

Journal of hepatology, 2014-04, Vol.60 (1), p.S412-S412

2014

Volltextzugriff (PDF)

Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course

Journal of hepatology, 2017, Vol.66 (1), p.S84-S85

2017

Volltextzugriff (PDF)

Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients

Journal of hepatology, 2016, Vol.64 (2), p.S185-S186

2016

Volltextzugriff (PDF)

743 HEPATITIS C INFECTED PATIENTS WITH A PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE. DO THEY EXIST AND IS THIS REALLY A GROUP WITH MILD DISEASE?

Journal of hepatology, 2008, Vol.48, p.S277-S277

2008

Volltextzugriff (PDF)

SAT-292 - Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme

Journal of hepatology, 2017, Vol.66 (1), p.S746-S747

2017

Volltextzugriff (PDF)

FRI-214 - Real world outcomes of DAA therapy for chronic hepatitis C virus infection in the HCV Research UK National cohort

Journal of hepatology, 2017, Vol.66 (1), p.S504-S504

2017

Volltextzugriff (PDF)

SAT-212 - Hepatitis C: awareness Through to Treatment (HepCATT) study: evaluation of an intervention designed to increase diagnosis and treatment of patients with hepatitis C virus infection in drug treatment settings

Journal of hepatology, 2017, Vol.66 (1), p.S712-S713

2017

Volltextzugriff (PDF)

879 ROLE OF SOLUBLE LECTIN L-FICOLIN IMMUNE RECOGNITION IN HEPATITIS C VIRUS INFECTION

Journal of hepatology, 2009, Vol.50, p.S320-S320

2009

Volltextzugriff (PDF)

Immunocompromised children and young people are at no increased risk of severe COVID-19

The Journal of infection, 2022-01, Vol.84 (1), p.31-39

2022

Volltextzugriff (PDF)

PS-158 - Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course

Journal of hepatology, 2017, Vol.66 (1), p.S84-S85

2017

Volltextzugriff (PDF)

Current knowledge and future perspectives on acute hepatitis C infection

Clinical microbiology and infection, 2015-08, Vol.21 (8), p.797.e9-797.e17

2015

Volltextzugriff (PDF)

PS097 - Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients

Journal of hepatology, 2016, Vol.64 (2), p.S185-S186

2016

Volltextzugriff (PDF)

Clinical virology

The Journal of infection, 2002-03, Vol.44 (2), p.104-104

Irving, W.L.

2002

Volltextzugriff (PDF)

Trent HCV study: mortality rates and ethnic differences in outcome

Journal of clinical virology, 2006, Vol.36, p.S10-S10

Irving, W.L.

2006

Volltextzugriff (PDF)

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

Genes and immunity, 2013-07, Vol.14 (5), p.286-290

2013

Volltextzugriff (PDF)

553 Steatosis in chronic hepatitis C and development of fibrosis: A prospective paired liver biopsy study in 292 patients

Journal of hepatology, 2006-04, Vol.44, p.S206-S206

2006

Volltextzugriff (PDF)

418 Occult hepatitis C infection in patients with histological hepatitis and negative serum PCR for HCV

Journal of hepatology, 2006-04, Vol.44, p.S157-S157

2006

Volltextzugriff (PDF)

Immunisation with Phage Displaying Peptides Representing Single Epitopes of the Glycoprotein G Can Give Rise to Partial Protective Immunity to HSV-2

Virology (New York, N.Y.), 2000-03, Vol.269 (1), p.47-53

2000

Volltextzugriff (PDF)

5 - Antimicrobial agents

Medical Microbiology, 2012, p.54-68

Eighteenth Edition, 2012

Volltextzugriff (PDF)

Hepatitis C in children: Role of serology in diagnosis

Hepatology (Baltimore, Md.), 1994-04, Vol.19 (4), p.I57-I57

1994

Volltextzugriff (PDF)

Antimicrobial agents

Medical Microbiology, 2012, p.54-68

Eighteenth Edition, 2012

Volltextzugriff (PDF)

The regulation of in vitro Epstein-Barr virus infection of lymphocytes from normal donors and patients with rheumatoid arthritis

Irving, W.L

1986

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(11)
Life Sciences & Biomedicine
(11)
Gastroenterology And Hepatology
(8)
Biological And Medical Sciences
(5)
Immunology
(5)
Infectious Diseases
(5)
Male
(5)
Animals
(4)
Female
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Virology
(4)
Adult
(3)
B-Lymphocytes - Immunology
(3)
Cross-Sectional Studies
(3)
Hepatitis C - Diagnosis
(3)
Herpesvirus 4, Human - Immunology
(3)
Mice
(3)
Microbiology
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis C: awareness Through to Treatment (HepCATT) study: evaluation of an intervention designed to increase diagnosis and treatment of patients with hepatitis C virus infection in drug treatment settings

Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme

Real world outcomes of DAA therapy for chronic hepatitis C virus infection in the HCV Research UK National cohort

P1012 ENHANCED LIVER FIBROSIS (ELF) TEST PERFORMS BETTER THAN HISTOLOGICAL PARAMETERS IN PREDICTING CLINICAL OUTCOMES IN PATIENTS WITH ADVANCED FIBROSIS DUE TO CHRONIC HEPATITIS C INFECTION

Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course

Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients

743 HEPATITIS C INFECTED PATIENTS WITH A PERSISTENTLY NORMAL ALANINE AMINOTRANSFERASE. DO THEY EXIST AND IS THIS REALLY A GROUP WITH MILD DISEASE?

SAT-292 - Liver function as measured by albumin-bilirubin score within decompensated patients receiving direct acting antiviral therapy within the Expanded Access Programme

FRI-214 - Real world outcomes of DAA therapy for chronic hepatitis C virus infection in the HCV Research UK National cohort

SAT-212 - Hepatitis C: awareness Through to Treatment (HepCATT) study: evaluation of an intervention designed to increase diagnosis and treatment of patients with hepatitis C virus infection in drug treatment settings

879 ROLE OF SOLUBLE LECTIN L-FICOLIN IMMUNE RECOGNITION IN HEPATITIS C VIRUS INFECTION

Immunocompromised children and young people are at no increased risk of severe COVID-19

PS-158 - Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course

Current knowledge and future perspectives on acute hepatitis C infection

PS097 - Antiviral Treatment in Patients with Advanced Hcv Cirrhosis Using Sofosbuvir and Ledipasvir/Daclatasvir with or without Ribavirin - 6 and 12 Month Outcomes Compared to Untreated Patients

Clinical virology

Trent HCV study: mortality rates and ethnic differences in outcome

CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection

553 Steatosis in chronic hepatitis C and development of fibrosis: A prospective paired liver biopsy study in 292 patients

418 Occult hepatitis C infection in patients with histological hepatitis and negative serum PCR for HCV

Immunisation with Phage Displaying Peptides Representing Single Epitopes of the Glycoprotein G Can Give Rise to Partial Protective Immunity to HSV-2

5 - Antimicrobial agents

Hepatitis C in children: Role of serology in diagnosis

Antimicrobial agents

The regulation of in vitro Epstein-Barr virus infection of lymphocytes from normal donors and patients with rheumatoid arthritis

Suchergebnisse filtern